Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Ipca Laboratories Ltd.
Change Company   
BSE Code 524494
ISIN Demat INE571A01038
Book Value 265.61
NSE Code IPCALAB
Dividend Yield % 0.25
Market Cap 401930.91
P/E 61.84
EPS 25.62
Face Value 1  
05-Dec-2024 Ipca Laboratories secures approval for voluntary ...
15-Nov-2024 Ipca Laboratories informs about newspaper publica...
04-Oct-2024 Ipca Laboratories informs about loss of share cer...
23-Sep-2024 Ipca Laboratories informs about notice of board m...
20-Sep-2024 Ipca Laboratories informs about disclosure
06-Sep-2024 IPCA Laboratories informs about disclosure
19-Aug-2024 IPCA Laboratories informs about analyst meet outc...
17-Aug-2024 Ipca Laboratories launches Diulcus
07-Aug-2024 IPCA Laboratories informs about disclosure
06-Aug-2024 Ipca Laboratories informs about media release
26-Jul-2024 IPCA Laboratories informs about details of loss o...
24-Jul-2024 Ipca Laboratories informs about board meeting
18-Jul-2024 Ipca Laboratories informs about book closure
18-Jul-2024 Ipca Laboratories informs about loss of share cer...
17-Jul-2024 IPCA Laboratories informs about business responsi...
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.